Evidence map›Paper›PMID 41524403›Full record

ArticlemBio2026

Differentiation-dependent proximity proteomics identifies novel host factors linked to HPV16 E2 function.

Claire D James, Aya Youssef, Apurva T Prabhakar, Jenny D Roe, Elinor Lu, Austin Witt, Sarita Giri, Molly L Bristol, Phoebe Bridy, Xu Wang and 3 more

Abstract read
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Claire D JamesVirginia Commonwealth University (VCU), Philips Institute for Oral Health Research, School of Dentistry, Richmond, Virginia, USA.ORCID 0000-0002-6816-1607
Aya YoussefVirginia Commonwealth University (VCU), Philips Institute for Oral Health Research, School of Dentistry, Richmond, Virginia, USA.
Apurva T PrabhakarVirginia Commonwealth University (VCU), Philips Institute for Oral Health Research, School of Dentistry, Richmond, Virginia, USA.ORCID 0000-0003-2266-7247
Jenny D RoeVirginia Commonwealth University (VCU), Philips Institute for Oral Health Research, School of Dentistry, Richmond, Virginia, USA.
Elinor LuVirginia Commonwealth University (VCU), Philips Institute for Oral Health Research, School of Dentistry, Richmond, Virginia, USA.
Austin WittVirginia Commonwealth University (VCU), Philips Institute for Oral Health Research, School of Dentistry, Richmond, Virginia, USA.
Sarita GiriVirginia Commonwealth University (VCU), Philips Institute for Oral Health Research, School of Dentistry, Richmond, Virginia, USA.
Molly L BristolVirginia Commonwealth University (VCU), Philips Institute for Oral Health Research, School of Dentistry, Richmond, Virginia, USA.ORCID 0000-0002-4259-8528
Phoebe BridyVirginia Commonwealth University (VCU), Philips Institute for Oral Health Research, School of Dentistry, Richmond, Virginia, USA.
Xu WangVirginia Commonwealth University (VCU), Philips Institute for Oral Health Research, School of Dentistry, Richmond, Virginia, USA.
Arjun RijalVCU Massey Comprehensive Cancer Center, Richmond, Virginia, USA.
Charles LyonsVCU Massey Comprehensive Cancer Center, Richmond, Virginia, USA.
Iain M MorganVirginia Commonwealth University (VCU), Philips Institute for Oral Health Research, School of Dentistry, Richmond, Virginia, USA.ORCID 0000-0002-4949-3032

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Renato Martins · 1985 to 2026
$51.0M
Determining how a Werner helicase (WRN) tumor suppressor complex regulates the human papillomavirus 16 life cycleR01DE029471 · NIDCR · VIRGINIA COMMONWEALTH UNIVERSITY · PI MORGAN, IAIN · 2021 to 2025
$2.8M
Mechanisms and consequences of human papillomavirus 16 E2 regulation of host gene transcriptionR21AI178143 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI MORGAN, IAIN · 2024 to 2025
$421k
NCI NIH HHS P30 CA016059NIAID NIH HHS R21 AI178143NIDCR NIH HHS R01 DE029471
6 · The paper itself

Abstract

Human papillomavirus 16 (HPV16) is a causative agent of oropharyngeal, cervical, and anogenital cancers. The viral E2 protein is essential for viral genome replication, transcriptional regulation, episome maintenance, and activation of the host DNA damage response. Despite its central role, the full network of HPV16 E2 interactions with host proteins remains incompletely defined, particularly under differentiating conditions, which support the complete viral life cycle. In this study, we used TurboID-based proximity labeling to characterize the interactome of HPV16 E2 and its known host partner protein TOPBP1 in both undifferentiated monolayer and differentiating keratinocytes. We generated stable keratinocyte lines expressing doxycycline-inducible TurboID-tagged HPV16 E2 and confirmed that the tagged protein retained transcriptional, replicative, and DNA damage-inducing functions. Mass spectrometry analysis of streptavidin-enriched proteins identified both known and novel E2-associated host factors, including chromatin regulators, DNA repair proteins, and nucleolar components. Comparative analysis revealed substantial overlap between E2 and TOPBP1 interactomes, and IMPORTANCE: Human papillomaviruses (HPVs) establish persistent infections in stratified epithelia and rely on host DNA damage and repair factors to support their replication. The E2 protein is central to viral genome replication and maintenance and depends heavily on its interaction with the host factor TOPBP1 for these functions. Here, we define the E2 and TOPBP1 interactomes in differentiating keratinocytes and identify nucleolin (NCL) as a critical differentiation- and TOPBP1-dependent E2 partner required for episomal genome stability. These findings expand the understanding of how HPV16 coordinates viral replication with host chromatin and DNA repair networks, uncovering a cooperative E2-TOPBP1-NCL axis that may represent a new target for antiviral intervention.

Indexed as

Cell DifferentiationDNA-Binding ProteinsHost-Pathogen InteractionsHuman papillomavirus 16Oncogene Proteins, ViralProteomicsCarrier ProteinsCell LineHumansKeratinocytesNuclear ProteinsNucleolinPapillomavirus InfectionsPhosphoproteinsRNA-Binding ProteinsVirus ReplicationCarrier ProteinsDNA-Binding ProteinsE2 protein, Human papillomavirus type 16Nuclear ProteinsNucleolinOncogene Proteins, ViralPhosphoproteinsRNA-Binding ProteinsTOPBP1 protein, humanDNA damage responseE2 proteinhuman papillomavirus type 16 (HPV16)nucleolinprotein-protein interactionsproximity proteomicsTOPBP1viral life cycle

Identifiers

PMID41524403
PMCPMC12892938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.